From: Quantification of lung water in heart failure using cardiovascular magnetic resonance imaging
Validation Cohort | Prospective Cohort | ||||||
---|---|---|---|---|---|---|---|
Normal | At-Risk | HFrEF | HFpEF | ||||
NYHA I/II | NYHA III/IV | NYHA I/II | NYHA III/IV | ||||
Patients, n | 53 | 82 | 36 | 15 | 52 | 18 | |
Male sex, n (%)* | 19 (84) | 16 (30) | 44 (54)† | 26 (72)† | 6 (40) | 30 (58)† | 4 (22) |
Age at CMR, years* | 51 ± 13 | 65 ± 11 | 64 ± 10 | 66 ± 10 | 67 ± 16 | 68 ± 12 | 76 ± 9† |
Height, cm* | 173 ± 11 | 168 ± 9 | 170 ± 10 | 172 ± 10† | 166 ± 9 | 170 ± 9 | 161 ± 11† |
Weight, kg* | 89 ± 21 | 70 ± 12 | 81 ± 16† | 89 ± 19† | 85 ± 18† | 88 ± 15† | 78 ± 19 |
BMI, kg/m2* | 29 ± 7 | 25 ± 3 | 28 ± 5† | 30 ± 5† | 31 ± 7† | 31 ± 5† | 30 ± 8† |
HR, min− 1 | 71 ± 22 | 70 ± 11 | 68 ± 13 | 72 ± 17 | 73 ± 12 | 69 ± 11 | 67 ± 12 |
Systolic BP, mmHg* | 137 ± 23 | 131 ± 21 | 139 ± 19† | 128 ± 21 | 121 ± 18 | 129 ± 18 | 132 ± 17 |
Diastolic BP, mmHg* | 77 ± 15 | 76 ± 10 | 82 ± 13† | 77 ± 18 | 71 ± 13 | 73 ± 14 | 74 ± 11 |
Comorbidities, n(%) | |||||||
Diabetes* | NA | 0 (0) | 19 (23)† | 14 (39)† | 7 (47)† | 18 (35)† | 8 (44)† |
Hypertension* | NA | 0 (0) | 74 (90)† | 21 (58)† | 8 (53)† | 38 (73)† | 15 (83)† |
CAD/MI* | NA | 0 (0) | 23 (28)† | 22 (61)† | 6 (40)† | 16 (31)† | 7 (39)† |
Current smoker* | NA | 2 (4) | 11 (13) | 2 (6) | 2 (13) | 8 (15)* | 0 (0) |
COPD* | NA | 0 (0) | 7 (9)† | 5 (14)† | 5 (33)† | 8 (15)† | 7 (39)† |
AFib* | NA | 0 (0) | 16 (20)† | 13 (36)† | 7 (47)† | 24 (46)† | 8 (44)† |
Medications at baseline, n(%) | |||||||
Beta blocker* | NA | 0 (0) | 32 (39)† | 32 (89)† | 13 (87)† | 43 (83)† | 16 (89)† |
ACEi or ARB* | NA | 0 (0) | 64 (78)† | 33 (92)† | 14 (93)† | 41 (79)† | 16 (89)† |
Laboratory results | |||||||
BNP, pg/ml* | 505 ± 465 | 31 ± 20 | 53 ± 68† | 244 ± 256† | 381 ± 391† | 144 ± 148† | 265 ± 205† |
Creatinine, umol/L | NA | 97 ± 140 | 82 ± 19 | 93 ± 25 | 98 ± 60 | 105 ± 43 | 100 ± 36 |
MRI measurements | |||||||
LVEF, %* | 37 ± 18 | 63 ± 6 | 61 ± 9 | 32 ± 9† | 34 ± 9† | 56 ± 8† | 59 ± 8† |
LVEDVi, ml/m2* | 122 ± 56 | 70 ± 11 | 73 ± 19 | 119 ± 42† | 115 ± 38† | 75 ± 24 | 75 ± 22 |
LV Massi, g/m2* | 99 ± 35 | 52 ± 10 | 61 ± 14† | 86 ± 23† | 82 ± 23† | 68 ± 13† | 65 ± 14† |
LV Mass / LVEDV* | 0.87 ± 0.25 | 0.76 ± 0.15 | 0.85 ± 0.16† | 0.75 ± 0.17 | 0.74 ± 0.19 | 0.95 ± 0.23† | 0.90 ± 0.22† |